Voting Closed
To find out who won, book a table at the British Private Equity Party Awards 2025 on Tuesday, 30 September at The Brewrey, London
Bridewell
Bridewell is a cybersecurity services company providing end-to-end consulting and 24×7 managed detection and response solutions to organisations operating across Critical National Infrastructure (CNI) and other regulated industries. GCP began its investment partnership with Bridewell in March 2021, to support Anthony Young and Scott Nicholson and the wider management team to deliver on their ambitious growth plans. GCP’s technology services specialism and partnership approach supported Bridewell to significantly invest in leadership, talent, systems and processes alongside refining their GTM proposition, developing proprietary technology, delivering strategic M&A and establishing international operations in the USA. In May 2025 GCP realised its investment in Bridewell to an investor group involving Oakley Capital, Eurazeo and Sagard NewGen. The deal delivered a return of 9.3x for GCP Fund V. As a result of the transaction Bridewell entered a new phase of its growth journey in partnership with I-TRACING, a leading French-managed cybersecurity services business and existing portfolio company of the Oakley, Eurazeo and Sagard investor group.
The partnership brought together the market leaders in two of the largest markets in Europe thereby creating the go-to independent European cybersecurity powerhouse, protecting enterprise and mid-market clients globally at a time of rapidly escalating cyber risk.
JMG
JMG Group is a leading UK insurance broker providing comprehensive risk management solutions to small and medium-sized enterprises and high-net worth individuals.
Synova Fund IV acquired JMG in an off-market transaction in 2020. Synova backed incumbent CEO Nick Houghton, with Tim Johnson (former CEO of Stackhouse Poland, a prior Synova insurance investment which generated 5.6x MOIC) joining as Executive Chair. Synova and management focused on building a scalable platform capable of high-volume acquisition and integration, while preserving strong local client relationships.
JMG completed 51 acquisitions since Synova’s investment and has delivered market-leading organic growth of ~13% between FY22-FY25 (FYE March). Driven by a differentiated operating model that removes administrative burden from revenue-generating staff.
Over four years, Synova built JMG into one of the UK’s 25 largest insurance brokers, scaling EBITDA from ~£2m to ~£40m, growing headcount from 60 to 750, and building out its in-house M&A, and data functions. The investment generated a 5.6x MOIC.
Following a highly competitive exit process Synova selected GTCR, a global private equity firm with deep sector experience, as its partner for the next phase of growth. Given the significant continued growth opportunity, we reinvested from Synova Fund V to support the next phase of JMG’s growth from a co-control minority position.
The successful exit of JMG Group exemplifies strategic execution in UK financial services. It reflects Synova’s thematic sourcing, hands-on value creation, and alignment with management—and marks the second time Synova has delivered a 5.6x return in UK insurance distribution.
Medik8
In June 2025, Inflexion sold its majority stake in premium skincare brand Medik8 to L'Oréal Groupe. This landmark transaction reflects robust value acceleration under Inflexion’s ownership where a business with industry-leading margins achieved 29% revenue CAGR and a 6x increase in D2C sales.
During Inflexion’s four-year investment, Medik8 achieved significant global growth, tripling its headcount and more than tripling its sales, expanding across Europe, Australia, and notably strengthening its US presence by increasing sales by >6x during the investment period.
With Inflexion’s backing, the brand enhanced its digital capabilities, supporting the 6x increase in D2C sales, and opened a 100,000 sq. ft. Net Zero Innovation Centre. Launched within the first year of partnership, the new site helped triple R&D and operational capacity, contributing to the successful launch of several award-winning products. Significant investment in organisational design supported founder succession and the appointment of a Chair, CEO, COO and CMO and new roles in digital, data, innovation and sustainability. Medik8 achieved B Corp certification in 2024, the first in its peer set to do so.
Inflexion retains a minority stake, enabling continued participation in Medik8’s growth under L'Oréal’s stewardship.
"Inflexion joined us in 2021 to help turn up the volume. They've been absolutely incredible. I’m truly delighted they remain part of this unique three-way partnership." Elliot Isaacs, Founder, Medik8.
MetaCompliance
Tenzing invested in MetaCompliance, a cybersecurity software company based in Northern Ireland, in January 2021 and exited in December 2024 - the first realisation from Fund II - delivering a 5.5x gross MOIC and 53% gross IRR.
Our thesis centred on accelerating growth through international expansion, M&A, and commercial enhancement, while preserving the founder-led culture. The founder chose Tenzing as a culturally aligned partner with deep SaaS experience and a hands-on Growth Team model.
Over our hold, we supported MetaCompliance across multiple growth levers: upgrading outbound sales, launching a new inbound marketing engine, establishing a development centre in Portugal, and completing two strategic acquisitions in Denmark and Germany - led by our Acquisitions Director. Our Sherpas also provided hands-on execution support to accelerate key initiatives. A major value driver was succession. We supported the founder’s transition while building a leadership team capable of scaling the business.
Financially, MetaCompliance tripled revenue from £10.1m (FY21) to £34.5m (FY25), expanded EBITDA margins by 10 percentage points, and grew its customer base by more than 2.5x. Notably, 3.7x of the return came from earnings growth.
The business was acquired by Keensight Capital through a targeted process managed by Baird, generating a strong result for both management and our investors.
Voting Closed
To find out who won, book a table at the British Private Equity Party Awards 2025 on Tuesday, 30 September at The Brewrey, London